Cellectar Biosciences rolls out new clinical trial data for cancer therapy
May 13, 2026
Cellectar Biosciences has rolled out new clinical trial data showing patients are responding well to one of its cancer therapies.  The drug development firm, which has roots in UW-Madison, recently announced 12-month follow-up results from Phase 2b of its CLOVER...
https://www.wispolitics.com/2026/cellectar-biosciences-rolls-out-new-clinical-trial-data-for-cancer-therapy/
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service